-transparent.png){kind=logo}
Concomitant administration of an antigen and antibodies of the respective specificity has been shown to result in reduced levels of actively produced antibodies. This has also recently been observed in a clinical trial on simultaneous passive and active immunization against tick-borne encephalitis virus (TBEV). In the current study the influence of simultaneous passive and active immunization on vaccine induced protective immunity against TBEV has been evaluated in a mouse model. Two immunizations with licensed whole-killed TBEV vaccines gave close to complete protection. Administration of human or mouse TBEV antibodies together with the first vaccine dose resulted in a significant reduction of vaccine induced protection against TBEV challenge. This effect was even more pronounced than that observed earlier on the levels of vaccine induced antibody.
T R Kreil, and
I Burger, and
E Attakpah, and
K Olas, and
M M Eibl
March 1999,
Vaccine,
T R Kreil, and
I Burger, and
E Attakpah, and
K Olas, and
M M Eibl
January 1991,
Vaccine,
T R Kreil, and
I Burger, and
E Attakpah, and
K Olas, and
M M Eibl
January 1997,
Molekuliarnaia biologiia,
T R Kreil, and
I Burger, and
E Attakpah, and
K Olas, and
M M Eibl
January 1985,
Zeitschrift fur Gerontologie,
T R Kreil, and
I Burger, and
E Attakpah, and
K Olas, and
M M Eibl
January 2016,
Therapeutische Umschau. Revue therapeutique,
T R Kreil, and
I Burger, and
E Attakpah, and
K Olas, and
M M Eibl
August 1990,
Zhurnal mikrobiologii, epidemiologii i immunobiologii,
T R Kreil, and
I Burger, and
E Attakpah, and
K Olas, and
M M Eibl
September 1996,
European journal of pediatrics,
T R Kreil, and
I Burger, and
E Attakpah, and
K Olas, and
M M Eibl
January 1994,
Przeglad epidemiologiczny,
T R Kreil, and
I Burger, and
E Attakpah, and
K Olas, and
M M Eibl
January 1987,
Archives of virology,
T R Kreil, and
I Burger, and
E Attakpah, and
K Olas, and
M M Eibl
July 2010,
Vaccine,
